Ardent Health (NYSE:ARDT) Price Target Lowered to $17.00 at Stephens

Ardent Health (NYSE:ARDT) had its target price lowered by research analysts at Stephens from $21.00 to $17.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Stephens’ target price would indicate a potential upside of 89.44% from the stock’s previous close.

Other research analysts have also recently issued reports about the company. Wall Street Zen raised Ardent Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. KeyCorp lowered their price target on Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, August 7th. The Goldman Sachs Group assumed coverage on shares of Ardent Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $19.00 price objective on the stock. UBS Group started coverage on shares of Ardent Health in a report on Wednesday, September 10th. They issued a “buy” rating and a $17.00 target price for the company. Finally, Weiss Ratings upgraded shares of Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $15.91.

Ardent Health Stock Down 3.5%

Shares of ARDT traded down $0.33 during midday trading on Friday, reaching $8.97. The stock had a trading volume of 621,454 shares, compared to its average volume of 408,432. The company has a market cap of $1.28 billion, a price-to-earnings ratio of 6.19, a PEG ratio of 6.21 and a beta of 0.44. The company’s fifty day simple moving average is $13.88 and its two-hundred day simple moving average is $13.36. Ardent Health has a 1-year low of $8.90 and a 1-year high of $17.91. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 2.00.

Ardent Health (NYSE:ARDT) last issued its earnings results on Wednesday, November 12th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.10. Ardent Health had a net margin of 3.24% and a return on equity of 19.19%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. Equities research analysts expect that Ardent Health will post 1.23 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health

Hedge funds have recently made changes to their positions in the business. Bank of New York Mellon Corp lifted its stake in shares of Ardent Health by 91.2% in the 1st quarter. Bank of New York Mellon Corp now owns 48,988 shares of the company’s stock worth $674,000 after acquiring an additional 23,373 shares during the period. Morse Asset Management Inc acquired a new position in shares of Ardent Health during the first quarter worth about $36,000. Y Intercept Hong Kong Ltd purchased a new position in Ardent Health during the first quarter worth about $142,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Ardent Health during the first quarter worth about $422,000. Finally, Vanguard Group Inc. lifted its position in Ardent Health by 368.9% in the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock valued at $18,296,000 after purchasing an additional 1,046,845 shares during the period.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.